Emerging as a promising avenue for treating the debilitating effects of MS Disease, regenerative therapy is rapidly gaining traction within the medical sector. While not a resolution, this innovative approach aims to restore damaged myelin coverings and mitigate neurological decline. Several clinical trials are currently being conducted, exploring